neurological disorder, brain disease, Q&A, Alzheimer's disease, Parkinson's disease, multiple sclerosis, motor neuron disease, neurodegeneration, blood-brain barrier, sex
Sex of Human Cells Matters in Studying Neurological Disease
Authors of a new review urge researchers to consider how the chromosomal sex of a cell affects experiments in research on neurodegeneration.
Sex of Human Cells Matters in Studying Neurological Disease
Sex of Human Cells Matters in Studying Neurological Disease

Authors of a new review urge researchers to consider how the chromosomal sex of a cell affects experiments in research on neurodegeneration.

Authors of a new review urge researchers to consider how the chromosomal sex of a cell affects experiments in research on neurodegeneration.

multiple sclerosis
herpes herpesvirus ms multiple sclerosis
Type of Herpes Virus Tied to Multiple Sclerosis
Katarina Zimmer | Jan 10, 2020
A study of 16,000 people suggests that human herpesvirus 6A is a risk factor for developing multiple sclerosis, reinvigorating a neglected hypothesis that the virus could be involved in triggering the disease.
ms multiple sclerosis autoimmune disease pregnancy t cells clones
MS Relief During Pregnancy Tied to Changes in T Cell Types
Ashley P. Taylor | Nov 15, 2019
Many dominant T cell variants decline during pregnancy and reappear afterward, possibly explaining why relapses of the autoimmune disease are less common when women are expecting.
Pelizaeus-Merzbacher disease neural stem cell transplantation
Neural Stem Cell Transplantation Crawls Toward the Clinic
Ashley P. Taylor | Oct 29, 2019
Several early-stage clinical trials indicate that implanting patients with the cells is safe. But whether they can alleviate neurological problems remains to be seen.
northwestern memorial hospital hsct hematopoietic stem cell clinical trial multiple sclerosis ms selma blair richard burt
Northwestern University Stem Cell Therapy Clinic Closes Abruptly
Katarina Zimmer | Sep 6, 2019
A Chicago-based center that has long operated a clinical trial program for stem cell therapies, has stopped recruiting further patients as its chief, Richard Burt, leaves for a research sabbatical.
microbiome
Do Commensal Microbes Stoke the Fire of Autoimmunity?
Amanda B. Keener | Jun 1, 2019
Molecules produced by resident bacteria and their hosts may signal immune cells to attack the body’s own tissues.
march 2019 the scientist profile
Master Decoder: A Profile of Kári Stefánsson
Anna Azvolinsky | Mar 1, 2019
A neurologist by training, Stefánsson founded Iceland-based deCODE Genetics to explore what the human genome can tell us about disease and our species’ evolution.
Infographic: Human Endogenous Retroviruses and Disease
Katarina Zimmer | Jan 1, 2019
Human endogenous retroviruses that colonized vertebrate DNA millions of years ago have long been dismissed as junk DNA, but researchers now know that they may play important roles in cancer, neurodegeneration, and other ailments.
Can Viruses in the Genome Cause Disease?
Katarina Zimmer | Jan 1, 2019
Clinical trials that target human endogenous retroviruses to treat multiple sclerosis, ALS, and other ailments are underway, but many questions remain about how these sequences may disrupt our biology.
Image of the Day: Telling Scans
Aggie Mika | Oct 16, 2017
In children’s brain scans, scientists uncovered signs of multiple sclerosis before the kids showed any symptoms of the disease.
Multiple Sclerosis: Is Yawning a Warning?
Benjamin Skuse | Sep 1, 2016
Neuropsychologist Simon Thompson found a possible link between yawning and multiple sclerosis. So what better way to get under the skin of his research than volunteering to take part in one of his experiments?
Toward Targeted Therapies for Autoimmune Disorders
Lawrence Steinman | Jun 1, 2016
Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.
B Cells Can Drive Inflammation in MS
Anna Azvolinsky | Oct 21, 2015
Researchers identify a subset of proinflammatory cytokine-producing B cells that may spark multiple sclerosis-related inflammation.  
New Hope for Alzheimer’s Blood Test
Jef Akst | Oct 19, 2015
Using autoantibodies as biomarkers, researchers could soon identify people at the highest risk of developing neurodegenerative diseases much earlier than existing methods.
Melatonin for MS?
Karen Zusi | Sep 11, 2015
Improvements in multiple sclerosis symptoms correlate with higher levels of the sleep hormone, a study finds.
Novartis Buys Rights to GSK MS Drug for $1 Billion
Kerry Grens | Aug 24, 2015
The multiple sclerosis treatment has yet to be tested in Phase 3 clinical trials.
Biotech Buys Autoimmune Firm for $7B
Kerry Grens | Jul 16, 2015
Celgene has purchased Receptos, developer of an experimental multiple sclerosis drug.
TB Vaccine Protects Against MS
Jef Akst | Dec 10, 2013
A vaccine developed to ward off tuberculosis may help prevent symptoms of multiple sclerosis, according to a new study.
Opinion: Predicting Perfect Storms
Magali Haas | Oct 30, 2013
On embracing technology and collaboration to tackle brain disorders like multiple sclerosis